Targeted investments with significant strategic value, mutual financial benefit and a faster path to market
We invest globally in aesthetic healthcare companies who are pursuing innovative, breakthrough science. Our primary goal is to link our expertise with advanced ideas and technologies from emerging companies or academic institutions.
Through the Merz Corporate Venture Capital Initiative, we offer up initial funding in the early stages of development of a company or technology and are committed to further investments in pace with the company’s progress. This could be alone, or in conjunction with other venture capital and investment funds.
In addition to financial backing, we provide extensive experience and a global network that allows our partners to work closely with management teams and fellow investors to create significant value.
Innovative ideas and technologies in aesthetics
We are seeking outstanding ideas and promising technologies in aesthetics that are capable of generating a high level of consumer interest, with a specific focus in anti-aging, skin rejuvenation and body-shaping or sculpting technology.
Although our interest is primarily focused on early stage projects and seed investments in aesthetics, our goal is to maximize the value of our entire portfolio, including the development of promising later stage investments and opportunities across all of Merz’s therapeutic focus areas.
A partner with a long-term horizon and strong complementary scientific resources
We pride ourselves on our long-standing commitment to both innovation and continuity. In line with our strategic interests, we are open to proactive and long-term engagement with our partners, and we hope to provide much more than financial backing.
We seek to directly connect our investments to Merz’ global infrastructure by offering access to relevant experts in our scientific research network and providing commercial insights into global to markets.